Carol G. Gallagher, PharmD

Carol Gallagher, Pharm.D., is an experienced board director currently serving as a director in both public and private companies. As a board director, she has been involved in advising on drug development, commercial strategy, public and private financings, licensing, and mergers and acquisitions.

From 2014 through 2023, Dr. Gallagher held Partner and advisor roles in biopharma venture investing at New Enterprise Associates. She also served as a Venture Partner at Frazier Healthcare from 2013-2014. Prior to her work in venture capital, she had a successful and varied career in both large and small biopharmaceutical companies including being the President and CEO of Calistoga Pharmaceuticals, which was acquired by Gilead in 2011. During her biopharma career, Dr. Gallagher has led commercial, drug development, and business development activities.

Dr. Gallagher studied chemistry at Vanderbilt University and received B.S. and Doctor of Pharmacy degrees from the University of Kentucky College of Pharmacy.